US Stock MarketDetailed Quotes

ACRO BIOMEDICAL CO LTD (ACBM)

Watchlist
  • 0.0260
  • 0.00000.00%
15min DelayTrading Mar 10 13:13 ET
1.56MMarket Cap-0.12P/E (TTM)

ACRO BIOMEDICAL CO LTD (ACBM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
0
0
0
0
Operating expense
1,163.99%115.1K
49.83%13.61K
-13.25%8.93K
-99.57%37.96K
-45.59%9.47K
-99.42%9.11K
-99.72%9.09K
-99.74%10.3K
-45.08%8.79M
-99.56%17.4K
Selling and administrative expenses
1,163.99%115.1K
49.83%13.61K
-13.25%8.93K
-98.92%37.96K
-45.59%9.47K
-98.70%9.11K
-99.31%9.09K
-99.31%10.3K
-40.68%3.52M
-98.82%17.4K
Research and development costs
----
----
----
--0
--0
--0
--0
----
-52.43%4.79M
--0
Provision for doubtful accounts
----
----
----
--0
--0
--0
----
----
--480K
--0
Operating profit
-1,163.99%-115.1K
-49.83%-13.61K
13.25%-8.93K
99.57%-37.96K
45.59%-9.47K
99.42%-9.11K
99.72%-9.09K
99.74%-10.3K
44.60%-8.79M
99.56%-17.4K
Net non-operating interest income expense
-141.32%-2.71K
-84.30%-1.95K
-43.29%-1.37K
-35.34%-4.34K
-43.62%-1.21K
-42.15%-1.12K
-33.97%-1.06K
-21.07%-954
-87.92%-3.21K
-6.61%-839
Non-operating interest expense
141.32%2.71K
84.30%1.95K
43.29%1.37K
35.34%4.34K
43.62%1.21K
42.15%1.12K
33.97%1.06K
21.07%954
87.92%3.21K
6.61%839
Other net income (expense)
-12K
0
Special income (charges)
----
----
----
--0
--0
--0
----
----
---12K
--0
-Write off
----
----
----
--0
--0
--0
----
----
--12K
--0
Income before tax
-1,051.72%-117.81K
-53.43%-15.56K
8.45%-10.3K
99.52%-42.3K
41.49%-10.67K
99.36%-10.23K
99.68%-10.14K
99.72%-11.25K
44.51%-8.81M
99.54%-18.24K
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-1,051.72%-117.81K
-53.43%-15.56K
8.45%-10.3K
99.52%-42.3K
41.49%-10.67K
99.36%-10.23K
99.68%-10.14K
99.72%-11.25K
44.51%-8.81M
99.54%-18.24K
Net income continuous Operations
-1,051.72%-117.81K
-53.43%-15.56K
8.45%-10.3K
99.52%-42.3K
41.49%-10.67K
99.36%-10.23K
99.68%-10.14K
99.72%-11.25K
44.51%-8.81M
99.54%-18.24K
Minority interest income
Net income attributable to the parent company
-1,051.72%-117.81K
-53.43%-15.56K
8.45%-10.3K
99.52%-42.3K
41.49%-10.67K
99.36%-10.23K
99.68%-10.14K
99.72%-11.25K
44.51%-8.81M
99.54%-18.24K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1,051.72%-117.81K
-53.43%-15.56K
8.45%-10.3K
99.52%-42.3K
41.49%-10.67K
99.36%-10.23K
99.68%-10.14K
99.72%-11.25K
44.51%-8.81M
99.54%-18.24K
Basic earnings per share
0
0
0
0
0
0
0
0
42.31%-0.15
0
Diluted earnings per share
0
0
0
0
0
0
0
0
42.31%-0.15
0
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit 0000
Operating expense 1,163.99%115.1K49.83%13.61K-13.25%8.93K-99.57%37.96K-45.59%9.47K-99.42%9.11K-99.72%9.09K-99.74%10.3K-45.08%8.79M-99.56%17.4K
Selling and administrative expenses 1,163.99%115.1K49.83%13.61K-13.25%8.93K-98.92%37.96K-45.59%9.47K-98.70%9.11K-99.31%9.09K-99.31%10.3K-40.68%3.52M-98.82%17.4K
Research and development costs --------------0--0--0--0-----52.43%4.79M--0
Provision for doubtful accounts --------------0--0--0----------480K--0
Operating profit -1,163.99%-115.1K-49.83%-13.61K13.25%-8.93K99.57%-37.96K45.59%-9.47K99.42%-9.11K99.72%-9.09K99.74%-10.3K44.60%-8.79M99.56%-17.4K
Net non-operating interest income expense -141.32%-2.71K-84.30%-1.95K-43.29%-1.37K-35.34%-4.34K-43.62%-1.21K-42.15%-1.12K-33.97%-1.06K-21.07%-954-87.92%-3.21K-6.61%-839
Non-operating interest expense 141.32%2.71K84.30%1.95K43.29%1.37K35.34%4.34K43.62%1.21K42.15%1.12K33.97%1.06K21.07%95487.92%3.21K6.61%839
Other net income (expense) -12K0
Special income (charges) --------------0--0--0-----------12K--0
-Write off --------------0--0--0----------12K--0
Income before tax -1,051.72%-117.81K-53.43%-15.56K8.45%-10.3K99.52%-42.3K41.49%-10.67K99.36%-10.23K99.68%-10.14K99.72%-11.25K44.51%-8.81M99.54%-18.24K
Income tax 0000000000
Net income -1,051.72%-117.81K-53.43%-15.56K8.45%-10.3K99.52%-42.3K41.49%-10.67K99.36%-10.23K99.68%-10.14K99.72%-11.25K44.51%-8.81M99.54%-18.24K
Net income continuous Operations -1,051.72%-117.81K-53.43%-15.56K8.45%-10.3K99.52%-42.3K41.49%-10.67K99.36%-10.23K99.68%-10.14K99.72%-11.25K44.51%-8.81M99.54%-18.24K
Minority interest income
Net income attributable to the parent company -1,051.72%-117.81K-53.43%-15.56K8.45%-10.3K99.52%-42.3K41.49%-10.67K99.36%-10.23K99.68%-10.14K99.72%-11.25K44.51%-8.81M99.54%-18.24K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1,051.72%-117.81K-53.43%-15.56K8.45%-10.3K99.52%-42.3K41.49%-10.67K99.36%-10.23K99.68%-10.14K99.72%-11.25K44.51%-8.81M99.54%-18.24K
Basic earnings per share 0000000042.31%-0.150
Diluted earnings per share 0000000042.31%-0.150
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to disrupt the stock market. On March 11 local time, Trump once again s Show More